Women’s Health Innovation Symposium: From Evidence to Investment

Despite rapid advancements in modern medicine, severe clinical data gaps and investment bottlenecks continue to hinder female-centric healthcare. Hosted by Nucleate Switzerland, this premier symposium is designed to break down traditional industry silos by convening a curated ecosystem of venture capitalists, entrepreneurs, clinical operators, and pharmaceutical executives. Together, we will explore actionable strategies to mobilize capital, leverage real-world evidence, and drive systemic change in gender-sensitive medicine. Join us for an evening of high-impact dialogue featuring some of the most prominent voices in the European healthcare sector. The summit will anchor on a keynote address from Reinhart Capital, followed by two core panels tackling the clinical evidence gap and the frontier of technological venture creation in women's health. Whether you are an investor scaling the next breakthrough, a clinician navigating off-label data, or an entrepreneur building the future of diagnostics, this event offers an unparalleled opportunity to forge the strategic partnerships needed to redefine the standard of care. This program is proudly sponsored by Blooridge and is supported by Health Science Club. Agenda 18:30 - 18:35 Nucleate Switzerland Welcome and Introduction 18:35 - 18:50 Keynote: Nina Portier Reinhart, Managing Director & Co-Founder, Reinhart Capital 18:50 - 19:30 Panel One: The Clinical Evidence Gap in Women’s Health Moderator: Tina Tianlan Cai, Nucleate Switzerland Leyla Hernandez Donoso: Real-World Evidence (RWE) Expert, Novo Nordisk Dr. Martin Kiebler: Physician, Obstetrics & Gynecology Elisabeth Mostofi: Partner, Capys Consulting GmbH | Commercialization Executive with 25+ Years in Global Pharma Laura Titaro: Co-Founder, Blooridge | Expert in Patient Advocacy and Insurance 19:30 - 19:35 Spotlight Presentation: Nicole Estermann, Managing Director, Artemis Women’s Health Foundation 19:35 - 19:45 Break 19:45 - 20:25 Panel Two: Venture Creation & Technological Innovation in Women’s Health Moderator: Lan Zuo Gillet, Founder, Tech4Eva Cinzia Donato: PhD, COO & CSO, Hera Biotech Lisa Falco: Co-Founder & CEO, N23 Health (Pioneering accessible breast cancer detection) | Forbes Contributor Alexandra Hirzel: Founder & Investor, The Scale Foundry Sanjana Rao: Co-Founder, Miyara (AI powered menopause Companion app) 20:25 - 20:30 Special Announcement: New Initiative Introduction 20:30 - 21:30 Networking Apéro